InsiderTrades.com logo
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

VAXX Insider Trading

Insider Ownership Percentage: 64.39%
Insider Buying (Last 12 Months): $365,119.53
Insider Selling (Last 12 Months): $2,663,021.36

Vaxxinity Insider Trading History Chart

This chart shows the insider buying and selling history at Vaxxinity by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vaxxinity Share Price & Price History

Current Price: $2.37
Price Change: ▲ Price Increase of +0.33 (16.18%)
As of 03/21/2023 05:23 PM ET

This chart shows the closing price history over time for VAXX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

Vaxxinity Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/23/2023Movers Lab Fund I Lp PrimeMajor ShareholderSell405,217$3.35$1,357,476.958,764,372View SEC Filing Icon  
12/1/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell270,964$2.97$804,763.089,180,710View SEC Filing Icon  
9/6/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell25,243$2.40$60,583.209,451,674View SEC Filing Icon  
8/25/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell22,757$2.33$53,023.819,476,917View SEC Filing Icon  
8/23/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell33,785$2.45$82,773.259,583,460View SEC Filing Icon  
6/16/2022Lou ReeseChairmanBuy100,000$1.99$199,000.0051,737,344View SEC Filing Icon  
6/13/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell92,569$2.43$224,942.679,617,245View SEC Filing Icon  
6/10/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell28,378$2.80$79,458.409,709,814View SEC Filing Icon  
6/9/2022Mei Mei HuInsiderBuy10,978$2.72$29,860.1651,637,344View SEC Filing Icon  
6/8/2022United Biomedical IncMajor ShareholderBuy10,000$2.95$29,500.0051,626,366View SEC Filing Icon  
4/27/2022Lou ReeseChairmanBuy4,807$3.58$17,209.0651,616,366View SEC Filing Icon  
4/26/2022United Biomedical IncMajor ShareholderBuy18,105$3.45$62,462.2551,611,559View SEC Filing Icon  
4/25/2022Mei Mei HuInsiderBuy8,038$3.37$27,088.0651,593,454View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

SEC Filings (Institutional Ownership Changes) for Vaxxinity (NASDAQ:VAXX)

20.84% of Vaxxinity stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VAXX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vaxxinity Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023Virtu Financial LLC17,842$25K0.0%N/A0.014%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC72,407$0.10M0.0%+348.0%0.057%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC107,594$0.15M0.0%-41.4%0.085%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC350,357$0.49M0.0%+4.0%0.278%Search for SEC Filing on Google Icon
2/10/2023Bank of America Corp DE552,423$0.77M0.0%-82.8%0.438%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP24,947$49K0.0%-80.6%0.020%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.2,212,186$4.38M0.0%+44.5%1.755%Search for SEC Filing on Google Icon
11/15/2022Prime Movers Lab LLC17,603,276$31.37M22.6%-1.4%13.968%Search for SEC Filing on Google Icon
11/15/2022Marshall Wace LLP178,258$0.35M0.0%-71.3%0.141%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.373,261$0.74M0.0%N/A0.296%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC183,635$0.36M0.0%-30.0%0.146%Search for SEC Filing on Google Icon
11/4/2022First Republic Investment Management Inc.199,022$0.39M0.0%N/A0.158%Search for SEC Filing on Google Icon
8/16/2022Creative Planning277,521$0.44M0.0%N/A0.221%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC213,620$0.34M0.0%N/A0.170%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC262,400$0.41M0.0%N/A0.209%Search for SEC Filing on Google Icon
8/10/2022Clarius Group LLC20,000$31K0.0%N/A0.016%Search for SEC Filing on Google Icon
7/22/2022Truist Financial Corp20,738$33K0.0%N/A0.016%Search for SEC Filing on Google Icon
7/21/2022Hollencrest Capital Management20,000$31K0.0%N/A0.016%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE15,858$68K0.0%+7,829.0%0.013%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.97,069$0.42M0.0%-56.1%0.077%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.55,121$0.24M0.0%-8.1%0.044%Search for SEC Filing on Google Icon
3/10/2022Prime Movers Lab LLC18,027,314$91.02M17.4%N/A14.377%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.1,001,670$5.62M0.0%N/A0.799%Search for SEC Filing on Google Icon
2/14/2022ETF Managers Group LLC37,884$0.21M0.0%N/A0.030%Search for SEC Filing on Google Icon
2/1/2022FNY Investment Advisers LLC4,847$27K0.0%N/A0.004%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vaxxinity logo
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.
Read More on Vaxxinity

Today's Range

Now: $2.37
Low: $2.00
High: $2.39

50 Day Range

MA: $2.67
Low: $1.94
High: $4.24

52 Week Range

Now: $2.37
Low: $1.24
High: $8.35

Volume

111,165 shs

Average Volume

373,270 shs

Market Capitalization

$298.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.92

Who are the company insiders with the largest holdings of Vaxxinity?

Vaxxinity's top insider investors include:
  1. Lou Reese (Chairman)
  2. Mei Mei Hu (Insider)
  3. United Biomedical Inc (Major Shareholder)
  4. Movers Lab Fund I Lp Prime (Major Shareholder)
Learn More about top insider investors at Vaxxinity.

Who are the major institutional investors of Vaxxinity?

Vaxxinity's top institutional shareholders include:
  1. Bank of America Corp DE — 0.44%
  2. Geode Capital Management LLC — 0.28%
  3. Renaissance Technologies LLC — 0.09%
  4. Millennium Management LLC — 0.06%
  5. Virtu Financial LLC — 0.01%
Learn More about top institutional investors of Vaxxinity stock.

Which institutional investors are selling Vaxxinity stock?

Within the previous quarter, VAXX stock was sold by these institutional investors:
  1. Bank of America Corp DE
  2. Renaissance Technologies LLC

Which institutional investors are buying Vaxxinity stock?

Within the last quarter, VAXX stock was purchased by institutional investors including:
  1. Millennium Management LLC
  2. Virtu Financial LLC
  3. Geode Capital Management LLC
During the previous year, these company insiders have bought Vaxxinity stock:
  1. Lou Reese (Chairman)
  2. Mei Mei Hu (Insider)
  3. United Biomedical Inc (Major Shareholder)
Learn More investors buying Vaxxinity stock.
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel